Navigation Links
Biomoda Appoints Three Business Leaders to Board of Directors
Date:5/5/2008

ced law

for more than 25 years and served on various boards, including

Commerce Exchange Bank and Southwest General Hospital. As a board

member of Commerce Exchange Bank, he was instrumental in raising share

value of the stock from $2.00 to a sale price of $13.00. He presently

is a director on the Systems Board at Southwest General Hospital, a

multi-million dollar company.

-- Lewis White, a major shareholder in Biomoda, is director and CEO of

New Energies Nebraska, LLC, a subsidiary of Standard Alcohol Company.

He has also served as CEO of Los Hojas Corporation and owned a

successful childcare business for 20 years, which he followed with an

interest in business investment through real estate and a thriving

food services business catering to niche markets. White attended the

University of Nebraska at Omaha where majored in Business

Administration and worked for the State of Nebraska.

With Biomoda's technology, clinicians can identify cancerous or aberrant cells extracted from samples of lung sputum; cancerous cells glow red under fluorescent light and can be detected under a microscope. Current diagnostic methods for lung cancer, including CT scans and X-rays, often detect the disease at more advanced stages. Biomoda's technology complements these tools by screening for signs of lung cancer at an earlier stage, ensuring that patients receive advanced tests at the appropriate time.

Earlier this year, Biomoda and the New Mexico Institute of Mining and Technology announced their partnership with the New Mexico Department of Veterans Services to conduct a $350,000 clinical study using Biomoda's proprietary testing technology for detection of early lung cancer in the state's veterans. The New Mexico state legislature recently allocated an additional $1.3 million in funding through the Interim Tobacco Settlement Committee
'/>"/>

SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. WallSt.net Announces Upcoming Interview With CEO of Biomoda
2. Biomoda Hires Manzano Strategies LLC to Spearhead Government Affairs Efforts
3. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
4. Biomoda Announces Collaborative Agreement With New Mexico Tech
5. Biomoda Hires Senior Scientist to Expand Research & Development Effort
6. Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
7. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
8. Codexis Appoints Singapore Laboratories Managing Director
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 S&P Capital IQ (MHFI) announced ... coverage on MabVax Therapeutics Holdings Inc . ... stage biotechnology company focused on the development of vaccine ... the treatment of cancer. MabVax has discovered a pipeline ... immune responses generated by patients who have been immunized ...
(Date:2/26/2015)... 26, 2015  23andMe, the leading personal genetics company, ... as Privacy Officer and Corporate Counsel. Black brings a ... as well as health care regulations. As a member ... responsible for reviewing, updating and enhancing the company,s privacy ... abroad. She joined the company January 5, 2015 and ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
(Date:2/26/2015)... PARK, Calif. , Feb. 26, 2015 ... released the latest version of the Governance Portal ... accomplish governance, risk and compliance (GRC) tasks across multiple ... also been updated to help customers better align their ... of the Treadway Commission ) requirements. In response to ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... Bio Inc. (ORC) a biotech company developing stem ... with the European Competent Authority in Seville, Spain, ... HYC750 in healthy male volunteers. The goal of ... pharmacokinetics and pharmacodynamics (induction of hematopoiesis) of HYC750, ...
... SHENYANG, China, Feb. 9 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: ... focused on researching,developing, manufacturing and marketing biopharmaceutical products ... Mr. Bo Tan as Chief Financial,Officer, effective February ... Mr.,Tan has been acting as the financial advisor ...
... DUBLIN, Ireland, February 9, Shire plc (LSE: SHP, NASDAQ: ... IV Notice letters from Barr Laboratories, Inc.,("Barr) and Mylan, ... in each case of the filing of an Abbreviated ... 750mg and 1gm FOSRENOL(R),(lanthanum carbonate). , ...
Cached Biology Technology:Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 33SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer 2Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2
(Date:2/23/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announced today ... DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND SYSTEM. ... payment method. Payment accounts may be selected via voice ... if both the speech (the word associated with the ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... and doctors from universities and industries around the ... project announced Sept. 4 to develop implantable devices ... designed to adapt to physical changes in a ... Naturally dissolving plates, screws, stents, and other devices ...
... 2008 As the anniversary of the September 11 ... a new podcast describing an array of technologies to ... podcast is the sixth episode in ACS,s acclaimed ... twice monthly, Global Challenges examines daunting problems facing society ...
... a gene enhancer, known as HACNS1, that may have contributed ... possibly also modifications in the ankle or foot that allow ... published in Science on Sept. 5, 2008. ... existence of human-specific gene enhancers, which are switches near genes ...
Cached Biology News:Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 2Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 3Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 4New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3
Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
... BODIPY FL ATP-Gamma-S binds to ... nucleotide the BODIPY FL fluorophore was ... In addition to its potential use ... ATP-Gamma-S thioether is an important new ...
... the industry standard microarray image analysis software ... and analysis tools, visualizations, automation capabilities, performance ... included with every GenePix scanner, and it ... and all types of arrays. A wide ...
... Simplify the process and you reduce the ... into the CEQ 8000. Developed using Beckman ... leadership in capillary electrophoresis technology, the CEQ ... system. This system automatically fills the capillary ...
Biology Products: